ANABEL TORRENTE LÓPEZ-rekin lankidetzan egindako argitalpenak (7)

2024

  1. Comprehensive physicochemical and functional analysis of pembrolizumab based on controlled degradation studies: Impact on antigen–antibody binding

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 194, pp. 131-147

2023

  1. Comprehensive physicochemical characterization of a peptide-based medicine: Teduglutide (Revestive®) structural description and stress testing

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 184, pp. 103-115

  2. QbD/PAT—State of the Art of Multivariate Methodologies in Food and Food-Related Biotech Industries

    Food Engineering Reviews, Vol. 15, Núm. 1, pp. 24-40

2022

  1. Combined use of UV and MS data for ICH Stability-Indication Method: Quantification and isoforms identification of intact nivolumab

    Microchemical Journal, Vol. 182

  2. Comprehensive Analysis of Nivolumab, A Therapeutic Anti-Pd-1 Monoclonal Antibody: Impact of Handling and Stress

    Pharmaceutics, Vol. 14, Núm. 4

2021

  1. The relevance of monoclonal antibodies in the treatment of COVID-19

    Vaccines, Vol. 9, Núm. 6

2020

  1. Use of subcutaneous tocilizumab to prepare intravenous solutions for COVID-19 emergency shortage: Comparative analytical study of physicochemical quality attributes

    Journal of Pharmaceutical Analysis, Vol. 10, Núm. 6, pp. 532-545